Trevena, Inc. Annual report pursuant to Section 13 and 15(d)

Accrued Expenses and Other Current Liabilities

12 Months Ended

Dec. 31, 2020

5. Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):


	December 31,
	2020		2019
Compensation and benefits	$	2,919	$	1,786
Commercial expenses		605		—
Legal expenses		784		86
Pharmaceutical development expenses		413		445
Accrued interest		—		18
Other accrued expenses and other current liabilities		447		68
Total accrued expenses and other current liabilities	$	5,168	$	2,403